HMOX1 and metabolic dysfunction-associated steatohepatitis: In conclusion, these data identify that a decrease in adipose and hepatic HO-1 is associated with an increase in adipose-derived NOV activation and that these perturbations can be regarded as key mediators in the development and progression of obesity-induced fibrosis and NASH.